Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Rising prevalence of psoriasis
3.2.3 Advancements in treatment
3.2.4 Growing awareness and diagnosis
3.2.5 Industry pitfalls & challenges
3.2.6 Stringent regulatory requirements
3.2.7 Side effects and safety concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Branded
5.3 Generics
Chapter 6 Market Estimates and Forecast, By Dosage Strength, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2. 10mg
6.3. 25mg
6.4. 50mg
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Psoriasis
7.3 Ichthyosis
7.4 Darier disease
7.5 Pityriasis rubra pilaris
7.6 Solid organ transplants
7.7 Grover's disease
7.8 Lichen planus
7.9 Lupus erythematosus
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Amneal Pharmaceuticals, Inc.
10.2 Biophore.
10.3 Chongqing Huapont Pharmaceutical Co., Ltd.
10.4 Globe International Limited
10.5 GSK Plc
10.6 Merck KGaA
10.7 Prasco Laboratories
10.8 SGPharma Pvt Ltd
10.9 Sionc Pharmaceuticals Pvt. Ltd.
10.10 Sun Pharma Industries Limited
